Metastatic neoplasm and Haemoglobin decreased

Summary:

Haemoglobin decreased is found among people with Metastatic neoplasm, especially for people who are male, 60+ old.

The study analyzes which people have Haemoglobin decreased with Metastatic neoplasm. It is created by eHealthMe based on reports of 27 people who have Metastatic neoplasm from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastatic neoplasm?

Metastatic neoplasm (spreadable cancer tumour) is found to be associated with 609 drugs and 516 conditions by eHealthMe. Check the latest studies of Metastatic neoplasm.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,408 drugs and 3,128 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.



On Jul, 06, 2026

27 people who have Metastatic Neoplasm and Haemoglobin Decreased are studied.

Would you have Haemoglobin decreased when you have Metastatic neoplasm?

Gender of people who have Metastatic Neoplasm and experienced Haemoglobin Decreased *:

  • female: 28 %
  • male: 72 %

Age of people who have Metastatic Neoplasm and experienced Haemoglobin Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 9.09 %
  • 60+: 72.73 %

Common co-existing conditions for these people *:

  1. Prostate Cancer: 2 people, 7.41%
  2. Type 2 Diabetes: 1 person, 3.70%
  3. Metastases To Bone (cancer spreads to bone): 1 person, 3.70%
  4. Breast Cancer Metastatic: 1 person, 3.70%
  5. Diabetes: 1 person, 3.70%
  6. Diarrhea: 1 person, 3.70%
  7. Gallbladder Cancer: 1 person, 3.70%
  8. Hepatocellular Carcinoma (liver cancer): 1 person, 3.70%
  9. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 1 person, 3.70%
  10. Multiple Myeloma (cancer of the plasma cells): 1 person, 3.70%

Common drugs taken by these people *:

  1. Sandostatin Lar: 8 people, 29.63%
  2. Lorazepam: 3 people, 11.11%
  3. Sutent: 3 people, 11.11%
  4. Camptosar: 2 people, 7.41%
  5. Lactulose: 2 people, 7.41%
  6. Megace: 2 people, 7.41%
  7. Morphine Sulfate: 2 people, 7.41%
  8. Prednisone: 2 people, 7.41%
  9. Sandostatin: 2 people, 7.41%
  10. Ambien: 2 people, 7.41%

Common symptoms for these people *:

  1. Diarrhea: 8 people, 29.63%
  2. Thrombocytopenia (decrease of platelets in blood): 8 people, 29.63%
  3. Weakness: 6 people, 22.22%
  4. Nausea (feeling of having an urge to vomit): 5 people, 18.52%
  5. Hot Flush (sudden feelings of heat): 5 people, 18.52%
  6. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 5 people, 18.52%
  7. Fainting (loss of consciousness and postural tone): 5 people, 18.52%
  8. White Blood Cell Count Decreased: 5 people, 18.52%
  9. Injection Site Mass: 4 people, 14.81%
  10. Injection Site Erythema (redness at injection site): 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Haemoglobin decreased:

All the conditions that are associated with Haemoglobin decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haemoglobin decreased and Metastatic neoplasm, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: